MCID: MLG088
MIFTS: 28

Malignant Germ Cell Tumor

Categories: Rare diseases

Aliases & Classifications for Malignant Germ Cell Tumor

MalaCards integrated aliases for Malignant Germ Cell Tumor:

Name: Malignant Germ Cell Tumor 50
Malignant Germ Cell Neoplasm 69
Germ Cell Cancer 69

Classifications:



Summaries for Malignant Germ Cell Tumor

MalaCards based summary : Malignant Germ Cell Tumor, also known as malignant germ cell neoplasm, is related to malignant germ cell tumor of cervix uteri and malignant germ cell tumor of the vagina. An important gene associated with Malignant Germ Cell Tumor is LDHA (Lactate Dehydrogenase A). The drugs Carboplatin and Cisplatin have been mentioned in the context of this disorder. Affiliated tissues include brain, bone and bone marrow, and related phenotype is Decreased shRNA abundance (Z-score < -2).

Related Diseases for Malignant Germ Cell Tumor

Diseases in the Germ Cells Tumors family:

Malignant Germ Cell Tumor

Diseases related to Malignant Germ Cell Tumor via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 25)
id Related Disease Score Top Affiliating Genes
1 malignant germ cell tumor of cervix uteri 12.1
2 malignant germ cell tumor of the vagina 12.0
3 malignant germ cell tumor of corpus uteri 12.0
4 malignant cardiac germ cell tumor 11.0
5 testicular malignant germ cell cancer 11.0
6 germ cells tumors 10.6
7 teratoma 9.9
8 gonadoblastoma 9.8
9 mediastinitis 9.8
10 mast cell disease 9.7
11 cryptorchidism 9.7
12 hepatitis 9.7
13 leukemia 9.7
14 urticaria pigmentosa 9.7
15 prostatitis 9.7
16 urticaria 9.7
17 gestational choriocarcinoma 9.7
18 histiocytosis 9.7
19 cerebritis 9.7
20 ovarian gonadoblastoma 9.7
21 choriocarcinoma 9.7
22 neuronitis 9.7
23 cavernous malformation 9.7
24 growing teratoma syndrome 9.7
25 malignant hyperthermia susceptibility type 4 8.9 CGB5 KPNA2 LDHA

Graphical network of the top 20 diseases related to Malignant Germ Cell Tumor:



Diseases related to Malignant Germ Cell Tumor

Symptoms & Phenotypes for Malignant Germ Cell Tumor

GenomeRNAi Phenotypes related to Malignant Germ Cell Tumor according to GeneCards Suite gene sharing:

26
id Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased shRNA abundance (Z-score < -2) GR00366-A-134 9.8 CGB5
2 Decreased shRNA abundance (Z-score < -2) GR00366-A-145 9.8 LDHA
3 Decreased shRNA abundance (Z-score < -2) GR00366-A-15 9.8 LDHA
4 Decreased shRNA abundance (Z-score < -2) GR00366-A-160 9.8 CGB5
5 Decreased shRNA abundance (Z-score < -2) GR00366-A-179 9.8 CGB5 LDHA
6 Decreased shRNA abundance (Z-score < -2) GR00366-A-180 9.8 LDHA
7 Decreased shRNA abundance (Z-score < -2) GR00366-A-184 9.8 LDHA
8 Decreased shRNA abundance (Z-score < -2) GR00366-A-203 9.8 LDHA
9 Decreased shRNA abundance (Z-score < -2) GR00366-A-212 9.8 LDHA
10 Decreased shRNA abundance (Z-score < -2) GR00366-A-38 9.8 LDHA
11 Decreased shRNA abundance (Z-score < -2) GR00366-A-59 9.8 CGB5 LDHA
12 Decreased shRNA abundance (Z-score < -2) GR00366-A-68 9.8 LDHA
13 Decreased shRNA abundance (Z-score < -2) GR00366-A-95 9.8 CGB5

Drugs & Therapeutics for Malignant Germ Cell Tumor

Drugs for Malignant Germ Cell Tumor (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 408)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Carboplatin Approved Phase 4,Phase 3,Phase 2,Phase 1 41575-94-4 10339178 498142 38904
2
Cisplatin Approved Phase 4,Phase 3,Phase 2,Phase 1 15663-27-1 84093 441203 2767
3
Etoposide Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 33419-42-0 36462
4
Ifosfamide Approved Phase 4,Phase 3,Phase 2,Phase 1 3778-73-2 3690
5
Mechlorethamine Approved Phase 4,Phase 3,Phase 1,Phase 2 51-75-2 4033
6
Lenograstim Approved Phase 4,Phase 2,Phase 3,Phase 1 135968-09-1
7
Nicotine Approved Phase 4 54-11-5 942 89594
8 Alkylating Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
9 Antineoplastic Agents, Phytogenic Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
10 Etoposide phosphate Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
11 Isophosphamide mustard Phase 4,Phase 3,Phase 2,Phase 1
12 Topoisomerase Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
13 Adjuvants, Immunologic Phase 4,Phase 3,Phase 1,Phase 2
14
Bleomycin Approved Phase 3,Phase 2 11056-06-7 5360373
15
Vinblastine Approved Phase 3,Phase 2,Phase 1 865-21-4 13342 241903
16
Cyclophosphamide Approved, Investigational Phase 3,Phase 2,Phase 1 50-18-0, 6055-19-2 2907
17
Oxaliplatin Approved, Investigational Phase 3,Phase 2,Phase 1 61825-94-3 5310940 9887054 43805 6857599
18
Paclitaxel Approved, Vet_approved Phase 3,Phase 2,Phase 1 33069-62-4 36314
19
Granisetron Approved, Investigational Phase 3 109889-09-0 3510
20
Carmustine Approved Phase 3,Phase 1,Phase 2 154-93-8 2578
21
Aminolevulinic acid Approved Phase 3,Phase 2,Phase 1 106-60-5 137
22
Dacarbazine Approved, Investigational Phase 3,Phase 2,Phase 1 4342-03-4 5351166
23
Dexamethasone Approved, Investigational, Vet_approved Phase 3,Phase 2,Phase 1 50-02-2 5743
24
Mesna Approved Phase 3,Phase 1,Phase 2 3375-50-6 598
25 Castor oil Approved, Vet_approved Phase 2, Phase 3
26
Methyltestosterone Approved Phase 2, Phase 3 58-18-4 6010
27
Testosterone Approved, Investigational Phase 2, Phase 3 58-22-0 6013
28
Levofloxacin Approved, Investigational Phase 3 100986-85-4 149096
29
Ofloxacin Approved Phase 3 82419-36-1 4583
30
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
31
Amphotericin B Approved, Investigational Phase 3 1397-89-3 14956 5280965
32
Miconazole Approved, Investigational, Vet_approved Phase 3,Phase 2,Phase 1,Early Phase 1 22916-47-8 4189
33
Caspofungin Approved Phase 3,Phase 2 179463-17-3, 162808-62-0 468682 2826718
34
Fluconazole Approved Phase 3 86386-73-4 3365
35
Itraconazole Approved, Investigational Phase 3 84625-61-6 55283
36
Palivizumab Approved, Investigational Phase 3 188039-54-5
37
Ribavirin Approved Phase 3 36791-04-5 37542
38
Captopril Approved Phase 3 62571-86-2 44093
39
Methylphenidate Approved, Investigational Phase 3 113-45-1 4158
40
Morphine Approved, Investigational Phase 3 57-27-2 5288826
41
Trioxsalen Approved Phase 3,Phase 2,Phase 1 3902-71-4 5585
42
Diphenhydramine Approved Phase 3 58-73-1, 147-24-0 3100
43
Promethazine Approved Phase 3 60-87-7 4927
44
Isotretinoin Approved Phase 3,Phase 2 4759-48-2 5538 5282379
45
Cyproheptadine Approved Phase 3 129-03-3 2913
46
Histamine Approved, Investigational Phase 3 75614-87-8, 51-45-6 774
47
Estradiol Approved, Investigational, Vet_approved Phase 3 50-28-2 5757
48
Ethinyl Estradiol Approved Phase 3 57-63-6 5991
49
Moxifloxacin Approved, Investigational Phase 3 354812-41-2, 151096-09-2 152946
50
Norgestimate Approved Phase 3 35189-28-7 6540478

Interventional clinical trials:

(show top 50) (show all 443)

id Name Status NCT ID Phase Drugs
1 Prospective Trial for the Diagnosis and Treatment of Intracranial Germ Cell Tumors Recruiting NCT01424839 Phase 4 Carboplatin, Etoposide, Ifosfamide;Cisplatin, etoposide, Ifosfamide (standard);Cisplatin, Etoposide, Ifosfamide (high dose)
2 Stereotactic Body Radiotherapy for Head and Neck Tumors Active, not recruiting NCT01344356 Phase 4
3 G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor Not yet recruiting NCT02933333 Phase 4
4 Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors Unknown status NCT00274950 Phase 3 carboplatin;cisplatin;etoposide;ifosfamide;vinblastine sulfate
5 Combination Chemotherapy With Bone Marrow Transplantation in Treating Men With Germ Cell Tumors Unknown status NCT00002566 Phase 3 carboplatin;cisplatin;cyclophosphamide;etoposide;ifosfamide;vinblastine sulfate
6 Magnetic Resonance Imaging and Computed Tomography in Patients With Stage I Seminoma of the Testicle Unknown status NCT00589537 Phase 3
7 Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors Unknown status NCT00104676 Phase 3 cisplatin;etoposide;ifosfamide;oxaliplatin;paclitaxel
8 Lerisetron Compared With Granisetron in Preventing Nausea and Vomiting in Men Being Treated With Radiation Therapy for Stage I Seminoma Unknown status NCT00004219 Phase 3 granisetron hydrochloride;lerisetron
9 Combination Chemotherapy in Treating Men With Germ Cell Cancer Unknown status NCT00003643 Phase 2, Phase 3 cisplatin;etoposide;paclitaxel
10 Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer Unknown status NCT01087268 Phase 3
11 Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma Unknown status NCT01656980 Phase 3 Carmustine
12 Androgen for Leydig Cell Proliferation Completed NCT01206270 Phase 2, Phase 3 Testosterone undecanoate;Castor Oil
13 Bleomycin, Etoposide, and Cisplatin in Treating Patients With Metastatic Germ Cell Cancer of the Testicles Completed NCT00324298 Phase 3 cisplatin;etoposide
14 Radiation Therapy Compared With Chemotherapy in Treating Patients With Stage I Testicular Cancer Completed NCT00003014 Phase 3 carboplatin
15 Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors Completed NCT00002596 Phase 3 carboplatin;cisplatin;cyclophosphamide;etoposide
16 Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy Completed NCT00716976 Phase 3 sodium thiosulfate
17 Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Men With Previously Untreated Germ Cell Cancer Completed NCT00003941 Phase 3 cisplatin;etoposide;ifosfamide
18 Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma Completed NCT00005590 Phase 3 levofloxacin
19 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
20 Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients Completed NCT00003938 Phase 3 liposomal amphotericin B
21 Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment Completed NCT00008359 Phase 3 caspofungin acetate;liposomal amphotericin B
22 Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation Completed NCT00003883 Phase 3 fluconazole;itraconazole
23 Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation Completed NCT00014391 Phase 3 ribavirin
24 Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation Completed NCT00004230 Phase 3 captopril;cyclophosphamide
25 E-MOSAIC Electronic Tool to Monitor Symptoms Completed NCT00477919 Phase 3
26 Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation Completed NCT00045292 Phase 3 acyclovir;acyclovir sodium;valacyclovir
27 Music Therapy or Book Discussion in Improving Quality of Life in Young Patients Undergoing Stem Cell Transplant Completed NCT00305851 Phase 3
28 Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant Completed NCT01305200 Phase 3 supersaturated calcium phosphate rinse
29 Fluorescence-guided Resection of Malignant Gliomas With 5-Aminolevulinic Acid Completed NCT00241670 Phase 3 5-aminolevulinic acid (5-ALA)
30 High Light and Low Light Dose PDT in Glioma Completed NCT00118222 Phase 3 porfimer sodium
31 A Trial of ABI-007 Versus Dacarbazine in Previously Untreated Patients With Metastatic Malignant Melanoma Completed NCT00864253 Phase 3 ABI-007;Dacarbazine
32 Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors Recruiting NCT03067181 Phase 3 Bleomycin;Carboplatin;Cisplatin;Etoposide
33 Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors Recruiting NCT02375204 Phase 3 paclitaxel;ifosfamide;cisplatin;pegylated G-CSF;G-CSF;carboplatin;etoposide phosphate
34 Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors Active, not recruiting NCT00053352 Phase 3 cisplatin;etoposide
35 TC or BEP in Treating Patients With Malignant Ovarian Germ Cell Tumors Enrolling by invitation NCT02429687 Phase 3 Paclitaxel;Carboplatin;Bleomycin;Etoposide;Cisplatin
36 Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer Terminated NCT01132547 Phase 3 cyproheptadine hydrochloride
37 Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors Terminated NCT00072215 Phase 3 cisplatin;ifosfamide;paclitaxel;vinblastine
38 Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant Terminated NCT00324324 Phase 3 moxifloxacin hydrochloride;Placebo
39 Imatinib Mesylate Treatment of Patients With Malignant Peripheral Nerve Sheath Tumors Terminated NCT00427583 Phase 2, Phase 3 imatinib mesylate
40 Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD) Terminated NCT00089141 Phase 3 mycophenolate mofetil;placebo
41 Procarbazine and Isotretinoin in Treating Patients With Recurrent Primary Malignant Gliomas Withdrawn NCT00003564 Phase 3 Isotretinoin;Procarbazine Hydrochloride
42 High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to First-Line Therapy Unknown status NCT01172912 Phase 2 carboplatin;cisplatin;dexamethasone;etoposide;ifosfamide
43 Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors Unknown status NCT00551122 Phase 1, Phase 2 cisplatin;gemcitabine hydrochloride;ifosfamide;paclitaxel
44 Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation Unknown status NCT00036712 Phase 2
45 SentoClone® Compared to Reference Treatment in Advanced Malignant Melanoma Unknown status NCT00991250 Phase 2 Temodal® or Dacarbazine Medac®
46 Carmustine Followed By Surgery in Treating Patients With Recurrent Supratentorial Malignant Glioma or Metastatic Brain Neoplasm Unknown status NCT00009854 Phase 1, Phase 2 carmustine in ethanol
47 Avastin / Irinotecan in Patients With Recurrent or Progressive Malignant Glioma Unknown status NCT01144988 Phase 2 Bevacizumab / Irinotecan
48 Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas Unknown status NCT00492687 Phase 2 carboplatin;tamoxifen citrate;temozolomide
49 A Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain Unknown status NCT01403311 Phase 2 5-Aminolevuline Acid
50 Temozolomide in Treating Patients With Recurrent or Progressive Malignant Glioma Unknown status NCT00004204 Phase 2 temozolomide

Search NIH Clinical Center for Malignant Germ Cell Tumor

Genetic Tests for Malignant Germ Cell Tumor

Anatomical Context for Malignant Germ Cell Tumor

MalaCards organs/tissues related to Malignant Germ Cell Tumor:

39
Brain, Bone, Bone Marrow, Breast, Lung, Kidney, T Cells

Publications for Malignant Germ Cell Tumor

Articles related to Malignant Germ Cell Tumor:

(show top 50) (show all 80)
id Title Authors Year
1
Novel loss of function mutation in KRIT1/CCM1 is associated with distinctly progressive cerebral and spinal cavernous malformations after radiochemotherapy for intracranial malignant germ cell tumor. ( 28488085 )
2017
2
Safety and efficacy of bleomycin/pingyangmycin-containing chemotherapy regimens for malignant germ cell tumor patients in the female genital system. ( 28160575 )
2017
3
Swyer's Syndrome with Mixed Ovarian Malignant Germ Cell Tumor and Ovarian Gonadoblastoma. ( 27411466 )
2016
4
Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the Malignant Germ Cell Tumor International Collaborative. ( 26485622 )
2016
5
Treatment Results of Extracranial Malignant Germ Cell Tumor with Regimens of Cisplatin, Vinblastine, Bleomycin or Carboplatin, Etoposide, and Bleomycin with Special Emphasis on the Sites of Vagina and Testis. ( 25769700 )
2015
6
Metastatic Treated Malignant Germ Cell Tumors: Is SALL4 a Better Marker Than Placental Alkaline Phosphatase? ( 25906119 )
2015
7
Feto-maternal outcomes of pregnancy complicated by ovarian malignant germ cell tumor: a systematic review of literature. ( 25150953 )
2014
8
Sacrococcygeal malignant germ cell tumor (SC-MGCT) with intraspinal extension. ( 24952799 )
2014
9
Neo-adjuvant chemotherapy in the treatment of advanced malignant germ cell tumors of ovary. ( 24145115 )
2014
10
Two case reports of a malignant germ cell tumor of ovary and a granulosa cell tumor: interest of tumoral immunochemistry in the identification and management. ( 24982844 )
2014
11
Impact of central surgical review in a study of malignant germ cell tumors. ( 25783295 )
2014
12
LIN28 Expression in malignant germ cell tumors downregulates let-7 and increases oncogene levels. ( 23774216 )
2013
13
Usefulness of OCT4/3 immunostain in pediatric malignant germ cell tumors. ( 22506928 )
2013
14
High-dose chemotherapy followed by autologous peripheral blood stem cell transplantation for recurrent primary mediastinal malignant germ cell tumor: A case report. ( 24373121 )
2013
15
Outcomes of combined modality therapy for patients with stage III or IV mediastinal malignant germ cell tumors. ( 23553421 )
2013
16
Brain metastases during follow-up of children and adolescents with extracranial malignant germ cell tumors: risk adapted management decision tree analysis based on data of the MAHO/MAKEI-registry. ( 22693072 )
2013
17
Is there a role for carboplatin in the treatment of malignant germ cell tumors? A systematic review of adult and pediatric trials. ( 22976789 )
2013
18
Utility of OCT3/4, TSPY and I^-catenin as biological markers for gonadoblastoma formation and malignant germ cell tumor development in dysgenetic gonads. ( 23396295 )
2013
19
CDX-2 expression in malignant germ cell tumors of the testes, intratubular germ cell neoplasia, and normal seminiferous tubules. ( 22895825 )
2012
20
Extracranial malignant germ cell tumors. ( 22706911 )
2012
21
A rare case of solitary metastatic non-seminomatous malignant germ cell tumor to the prostate. ( 23040630 )
2012
22
Overexpression of karyopherin 2 in human ovarian malignant germ cell tumor correlates with poor prognosis. ( 22962582 )
2012
23
Diagnostic utility of CD117, CD133, SALL4, OCT4, TCL1 and glypican-3 in malignant germ cell tumors of the ovary. ( 22448662 )
2012
24
Delayed Recognition of Disorders of Sex Development (DSD): A Missed Opportunity for Early Diagnosis of Malignant Germ Cell Tumors. ( 22315593 )
2012
25
Malignant germ cell tumors associated with Swyer syndrome. ( 21225934 )
2011
26
Unusual liver locations of growing teratoma syndrome in ovarian malignant germ cell tumors. ( 24371596 )
2011
27
Evaluation of neoadjuvant therapy in patients with nongerminomatous malignant germ cell tumors. ( 21456918 )
2011
28
Identification of microRNAs From the miR-371~373 and miR-302 clusters as potential serum biomarkers of malignant germ cell tumors. ( 21173133 )
2011
29
Therapy-associated secondary tumors in patients with non-germinomatous malignant germ cell tumors. ( 21533838 )
2011
30
Malignant germ cell tumors display common microRNA profiles resulting in global changes in expression of messenger RNA targets. ( 20332240 )
2010
31
Proton beam therapy for loco-regional control of a recurrent mixed malignant germ cell tumor of the skull in a 22-month-old girl. ( 20514623 )
2010
32
Modified grading system for clinical outcome of intracranial non-germinomatous malignant germ cell tumors. ( 22966355 )
2010
33
Family history of cancer and malignant germ cell tumors in children: a report from the Children's Oncology Group. ( 19842050 )
2010
34
Rete testis invasion by malignant germ cell tumor and/or intratubular germ cell neoplasia: what is the significance of this finding? ( 20573373 )
2010
35
Clinicopathologic characteristics of malignant germ cell tumors in the ovaries of Korean women: a Korean Gynecologic Oncology Group Study. ( 19258947 )
2009
36
Survival after an antiangiogenetic therapy and surgery in a wide spread growing teratoma originating from a testicular mixed malignant germ cell tumor. ( 19437360 )
2009
37
Carbon 11-labeled methionine positron emission tomography for detection of residual viable tumor cells after adjuvant therapy in nongerminomatous malignant germ cell tumors in 2 cases including an autopsy case. ( 18262610 )
2009
38
Diagnostic value of lectin reactive alpha-fetoprotein for neoinfantile hepatic tumors and malignant germ cell tumors: preliminary study. ( 18525461 )
2008
39
Comprehensive staging allows for excellent outcome in patients with localized malignant germ cell tumor of the ovary. ( 18948812 )
2008
40
Regression pattern of alpha fetoprotein level changed after treatment of malignant germ cell tumor. ( 18575279 )
2008
41
Pediatric malignant germ cell tumors show characteristic transcriptome profiles. ( 18519683 )
2008
42
The prevalence and prognostic impact of lymph node metastasis in malignant germ cell tumors of the ovary. ( 18571705 )
2008
43
False-positive serum human chorionic gonadotropin (HCG) in a male patient with a malignant germ cell tumor of the testis: a case report and review of the literature. ( 18984875 )
2008
44
Chemotherapy for the treatment of children and adolescents with malignant germ cell tumors. ( 18612144 )
2008
45
Malignant germ cell tumors of the ovary: a review of 41 cases and risk factors for recurrence. ( 19115694 )
2008
46
Viable malignant germ cell tumor in the postchemotherapy retroperitoneal lymph node dissection specimen: can it be predicted using clinical parameters? ( 16944534 )
2006
47
High lactate dehydrogenase isoenzyme 1 in a patient with malignant germ cell tumor is attributable to aberrant methylation of the LDHA gene. ( 15297388 )
2004
48
Management of primary malignant germ cell tumor of the mediastinum. ( 15342665 )
2004
49
Congenital mixed malignant germ cell tumor involving cerebrum and orbit. ( 12825484 )
2003
50
Re: organ sparing surgery for malignant germ cell tumor of the testis. ( 12187245 )
2002

Variations for Malignant Germ Cell Tumor

Expression for Malignant Germ Cell Tumor

Search GEO for disease gene expression data for Malignant Germ Cell Tumor.

Pathways for Malignant Germ Cell Tumor

GO Terms for Malignant Germ Cell Tumor

Sources for Malignant Germ Cell Tumor

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....